SHOC2 Is a Novel Cause of Central Conducting Lymphatic Anomaly.
Jessica C Ding, Benjamin A Sempowski, Lola Zerbib et al.
✦ AI-curated · Sources linked
Case in brief
A patient with complex congenital heart disease developed refractory chylothorax after surgery. Lymphatic imaging showed abnormal intercostal lymphatic perfusion consistent with central conducting lymphatic anomaly (CCLA) and suggestive of a RASopathy. Genetic testing identified a SHOC2 p.(Ala308Val) variant of uncertain significance. Functional studies supported pathogenicity: zebrafish expressing the variant developed pericardial edema, caudal plexus cystic malformations, and thoracic duct dilation. Trametinib treatment did not improve the patient’s condition; immunoblot findings suggested a possible non-canonical mTOR mechanism.
What made this case unusual
The case links a SHOC2 variant to CCLA, with functional evidence of lymphatic malformations and findings suggesting a non-canonical mTOR mechanism rather than the expected RAS-MAPK pathway.
Diagnostic / clinical pearl
In refractory postoperative chylothorax, lymphatic imaging can reveal CCLA; genetic and functional evaluation may help assess a variant of uncertain significance when a RASopathy is suspected.